Market Cap 2.40M
Revenue (ttm) 0.00
Net Income (ttm) -9.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 20,100
Avg Vol 93,396
Day's Range N/A - N/A
Shares Out 704,000.00
Stochastic %K 17%
Beta 1.41
Analysts Hold
Price Target $18.00

Company Profile

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated/ weight loss with cancer; and ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, depression, post-traumat...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 925 7049
Address:
505 Lomas Santa Fe, Suite 160, Solana Beach, United States
aim97
aim97 Oct. 23 at 1:25 PM
$ARTL whats with the reversal i didnt get a chance to DCA at sub 3.20 like i wanted. hopefully quickly up so i can exit.
1 · Reply
Foamius2
Foamius2 Oct. 22 at 4:39 PM
$ARTL Daniel Fart is out of 95% of his position-good riddance
0 · Reply
ttesty
ttesty Oct. 22 at 1:53 PM
$ENSC is almost $1.80. Keep falling. $ARTL ftw.
0 · Reply
elmono
elmono Oct. 21 at 11:49 AM
$ARTL As a result of ongoing discussions with potential partners and the supportive clinical profile of ART27.13 for CACS, Artelo does not envision the need to internally fund a Phase 3 trial and believes a licensing transaction represents the most value-accretive path forward for shareholders. “This morning’s interim results highlight the potential of ART27.13 to become an FDA and internationally approved therapy for cancer anorexia-cachexia syndrome, an underserved, multi-billion-dollar potential market,” said Gregory D. Gorgas, President and CEO of Artelo. “Based on strong interest from multiple pharmaceutical companies, and given the strength of our newly released data, our immediate strategy is to secure a development partner to efficiently advance ART27.13 through registrational trials. We plan to provide further updates as soon as practical.” Soon 2 months and nothing ….,how about that strong interest, you F’Ups. 😂😂🫵
1 · Reply
YolandaMantel1102
YolandaMantel1102 Oct. 20 at 4:18 PM
$ARTL evolving in biotech, AITX evolving in automation — the latest update reflects consistent growth and rising recognition.
0 · Reply
StockHounding
StockHounding Oct. 19 at 1:58 AM
$BCG : Bids climbing gradually Yeah, no need to slap here Just keep bid stacking until squeeze Iit's going to explode No borrow, no floater $CDTG manufactured price movement $ARTL ready as F $PNBK next squeeze? $DTSS just hanging out 
0 · Reply
MrTicker
MrTicker Oct. 17 at 9:08 PM
$ARTL Oct 17 (Reuters) - Artelo Biosciences Inc(ARTL): * ARTELO BIOSCIENCES INC(ARTL) - ENTERS COOPERATION LETTER AGREEMENT WITH DANIEL S. FARB AND CERTAIN OF HIS AFFILIATES - SEC FILING * ARTELO BIOSCIENCES INC(ARTL) - FARB AGREED WITHDRAWS NOMINATION OF CANDIDATES FOR ELECTION TO BOARD AT 2025 ANNUAL MEETING - SEC FILING * ARTELO BIOSCIENCES INC(ARTL) - FARB AND AFFILIATES AGREE TO STANDSTILL RESTRICTIONS AND VOTING COMMITMENTS - SEC FILING Source text: Further company coverage:
0 · Reply
MrTicker
MrTicker Oct. 17 at 9:08 PM
$ARTL BRIEF-Artelo Biosciences enters cooperation letter agreement with Daniel S. Farb - SEC filing REUTERS 4:06 PM ET 10/17/2025
0 · Reply
MrTicker
MrTicker Oct. 17 at 9:03 PM
$ARTL updated 13D Form SCHEDULE 13D/A ARTELO BIOSCIENCES, INC. Filed by: Farb Daniel Stuart 10K WIZARD 4:02 PM ET 10/17/2025 http://archive.fast-edgar.com/20251017/AF28K622U2223ZZ2222O2ZEPDMTUZ222V272 Filed on: October 17, 2025
0 · Reply
Paraboljoker
Paraboljoker Oct. 16 at 9:40 PM
$SUGP BIO/Hospital contract 11M🗞️ Worth Entire mcap 400k float, numers dont lie this will blow Sector hot🔥 / / $NCT $XBP $ARTL $ZBIO
0 · Reply
Latest News on ARTL
Artelo Biosciences Analyst See It As An Emerging Biotech

Jul 8, 2025, 3:06 PM EDT - 3 months ago

Artelo Biosciences Analyst See It As An Emerging Biotech


Artelo Biosciences Announces Reverse Stock Split

Jun 11, 2025, 8:30 AM EDT - 4 months ago

Artelo Biosciences Announces Reverse Stock Split


aim97
aim97 Oct. 23 at 1:25 PM
$ARTL whats with the reversal i didnt get a chance to DCA at sub 3.20 like i wanted. hopefully quickly up so i can exit.
1 · Reply
Foamius2
Foamius2 Oct. 22 at 4:39 PM
$ARTL Daniel Fart is out of 95% of his position-good riddance
0 · Reply
ttesty
ttesty Oct. 22 at 1:53 PM
$ENSC is almost $1.80. Keep falling. $ARTL ftw.
0 · Reply
elmono
elmono Oct. 21 at 11:49 AM
$ARTL As a result of ongoing discussions with potential partners and the supportive clinical profile of ART27.13 for CACS, Artelo does not envision the need to internally fund a Phase 3 trial and believes a licensing transaction represents the most value-accretive path forward for shareholders. “This morning’s interim results highlight the potential of ART27.13 to become an FDA and internationally approved therapy for cancer anorexia-cachexia syndrome, an underserved, multi-billion-dollar potential market,” said Gregory D. Gorgas, President and CEO of Artelo. “Based on strong interest from multiple pharmaceutical companies, and given the strength of our newly released data, our immediate strategy is to secure a development partner to efficiently advance ART27.13 through registrational trials. We plan to provide further updates as soon as practical.” Soon 2 months and nothing ….,how about that strong interest, you F’Ups. 😂😂🫵
1 · Reply
YolandaMantel1102
YolandaMantel1102 Oct. 20 at 4:18 PM
$ARTL evolving in biotech, AITX evolving in automation — the latest update reflects consistent growth and rising recognition.
0 · Reply
StockHounding
StockHounding Oct. 19 at 1:58 AM
$BCG : Bids climbing gradually Yeah, no need to slap here Just keep bid stacking until squeeze Iit's going to explode No borrow, no floater $CDTG manufactured price movement $ARTL ready as F $PNBK next squeeze? $DTSS just hanging out 
0 · Reply
MrTicker
MrTicker Oct. 17 at 9:08 PM
$ARTL Oct 17 (Reuters) - Artelo Biosciences Inc(ARTL): * ARTELO BIOSCIENCES INC(ARTL) - ENTERS COOPERATION LETTER AGREEMENT WITH DANIEL S. FARB AND CERTAIN OF HIS AFFILIATES - SEC FILING * ARTELO BIOSCIENCES INC(ARTL) - FARB AGREED WITHDRAWS NOMINATION OF CANDIDATES FOR ELECTION TO BOARD AT 2025 ANNUAL MEETING - SEC FILING * ARTELO BIOSCIENCES INC(ARTL) - FARB AND AFFILIATES AGREE TO STANDSTILL RESTRICTIONS AND VOTING COMMITMENTS - SEC FILING Source text: Further company coverage:
0 · Reply
MrTicker
MrTicker Oct. 17 at 9:08 PM
$ARTL BRIEF-Artelo Biosciences enters cooperation letter agreement with Daniel S. Farb - SEC filing REUTERS 4:06 PM ET 10/17/2025
0 · Reply
MrTicker
MrTicker Oct. 17 at 9:03 PM
$ARTL updated 13D Form SCHEDULE 13D/A ARTELO BIOSCIENCES, INC. Filed by: Farb Daniel Stuart 10K WIZARD 4:02 PM ET 10/17/2025 http://archive.fast-edgar.com/20251017/AF28K622U2223ZZ2222O2ZEPDMTUZ222V272 Filed on: October 17, 2025
0 · Reply
Paraboljoker
Paraboljoker Oct. 16 at 9:40 PM
$SUGP BIO/Hospital contract 11M🗞️ Worth Entire mcap 400k float, numers dont lie this will blow Sector hot🔥 / / $NCT $XBP $ARTL $ZBIO
0 · Reply
elmono
elmono Oct. 15 at 10:52 PM
$ARTL nobody cares about all these meetings….only 1 thing that this scam needs to do:
0 · Reply
Foamius2
Foamius2 Oct. 15 at 4:09 PM
$ARTL Wheres Daniel Fart? Big hat no cattle!
0 · Reply
DARKP00L
DARKP00L Oct. 15 at 1:23 PM
$ARTL 09:18 on Oct. 15 2025 Artelo Biosciences Reports Phase 1 And 2 Data For ART26.12 And ART27.13, Highlighting Safety And Significant Weight Gain In Cancer Anorexia Trial #tradeideas
0 · Reply
MrTicker
MrTicker Oct. 15 at 1:19 PM
$ARTL Artelo Biosciences Reports Phase 1 And 2 Data For ART26.12 And ART27.13, Highlighting Safety And Significant Weight Gain In Cancer Anorexia Trial BENZINGA 8:18 AM ET 10/15/2025 ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ART27.13 Interim Phase 2 Data Showed Substantial Weight Gain and Activity Improvements in the Treated Patients versus Placebo
0 · Reply
MrTicker
MrTicker Oct. 15 at 1:16 PM
$ARTL ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ART27.13 Interim Phase 2 Data Showed Substantial Weight Gain and Activity Improvements in the Treated Patients versus Placebo SOLANA BEACH, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.(ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced that Professor Saoirse O’Sullivan, Vice President of Translational Sciences at Artelo Biosciences(ARTL), is presenting expanded data from Artelo’s lead Fatty Acid Binding Protein 5 (FABP5) inhibitor, ART26.12, Single Ascending Dose (SAD) Study at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit, taking place October 15–16, 2025, in Boston, Massachusetts. eS).
0 · Reply
MrTicker
MrTicker Oct. 15 at 1:16 PM
$ARTL Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit GLOBENEWSWIRE 8:15 AM ET 10/15/2025
0 · Reply
elmono
elmono Oct. 13 at 2:29 PM
$ARTL push it down further and we go in liquidation mode on this ticker 🙏
0 · Reply
elmono
elmono Oct. 13 at 1:51 PM
$ARTL all these nanocaps suck….but this one in the bottom category 😂😂😂
0 · Reply
elmono
elmono Oct. 13 at 1:51 PM
$ARTL master scam outfit….😂😂😂
0 · Reply
StockChiefs
StockChiefs Oct. 12 at 5:49 PM
MTEX has only 600k shares outstanding and started to make its move up Friday! Don't miss MTEX . I would rather buy before they run 200% up.. 💎 Spiked towards $15 recently . Looks like once people find MTEX we could see a squeeze up again! $LUCY $WETH.X $ERNA $ARTL will run soon
0 · Reply
ttesty
ttesty Oct. 10 at 11:27 PM
$ENSC gonna get crushed by $ARTL.
1 · Reply
aim97
aim97 Oct. 10 at 4:30 PM
$ARTL bleeeding out its ass. mfer
0 · Reply